The diverse expression of the WT1 gene in patients with acquired bone marrow failure syndromes

被引：2

作者：

You, Yahong ^{[1
]}

Huo, Jiali ^{[1
]}

Lu, Shihong ^{[1
]}

Shao, Yingqi ^{[1
]}

Ge, Meili ^{[1
]}

Shi, Jun ^{[1
]}

Li, Xingxin ^{[1
]}

Huang, Jinbo ^{[1
]}

Huang, Zhendong ^{[1
]}

Zhang, Jing ^{[1
]}

Wang, Min ^{[1
]}

Nie, Neng ^{[1
]}

Zheng, Yizhou ^{[1
]}

机构：

[1] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China

来源：

LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 04期

基金：

中国国家自然科学基金;

关键词：

Anemia; aplastic; bone marrow failure; WT1; WILMS-TUMOR GENE; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; HYPOPLASTIC MYELODYSPLASTIC SYNDROME; HEMATOPOIETIC PROGENITOR CELLS; MYELOID-LEUKEMIA PATIENTS; APLASTIC-ANEMIA; PERIPHERAL-BLOOD; RESIDUAL DISEASE; MESSENGER-RNA; DIAGNOSIS;

D O I：

10.1080/10428194.2017.1352092

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Acquired bone marrow failure syndromes (aBMFS) encompass a wide range of diseases. A study to investigate WT1 expression in BM was conducted in 387 patients with aBMFS in China. The WT1 level in patients with aplastic anemia (AA) was significantly lower than that in patients with paroxysmal nocturnal hemoglobinuria (PNH, p=.023) and myelodysplastic syndrome (MDS, p<.001). In addition, the WT1 level in patients with MDS significantly increased as the disease progressed to an advanced stage. Patients with hypoplastic MDS had a differentiated expression level of WT1 compared with that of NSAA (p<.001). Furthermore, post-treatment patients of AA with partial response (PR) or complete response (CR) status had relatively higher WT1 levels than those with naive AA (p=.017, p=.003, respectively). Thus, the WT1 expression level could be a useful genetic marker for routine clinical work in aBMFS.

引用

页码：950 / 957

页数：8

共 50 条

[41] THE ASSOCIATION OF REDUCTION OF WT1 TRANSCRIPTS IN BONE MARROW AND OUTCOMES IN ACUTE MYELOID LEUKEMIA PATIENTS
Shibasaki, Y.
Tanaka, T.
Miyakoshi, S.
Fuse, K.
Kozakai, T.
Kobayashi, H.
Ushiki, T.
Moriyama, M.
Takizawa, J.
Narita, M.
Takahashi, M.
Sone, H.
Masuko, M.
HAEMATOLOGICA, 2014, 99 : 565 - 566
[42] Single-cell genomics in acquired bone marrow failure syndromes
Wu, Zhijie
Young, Neal S.
BLOOD, 2023, 142 (14) : 1193 - 1207
[43] Cytokine gene polymorphisms in acquired bone marrow failure
Gidvani, Vinod
Ramkissoon, Shakti
Sloand, Elaine M.
Young, Neal S.
AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (08) : 721 - 724
[44] CLINICAL USEFULNESS OF WT1 MRNA EXPRESSION IN BONE MARROW DETECTED USING A NEW WT1 MRNA ASSAY KIT FOR MONITORING ACUTE MYELOID LEUKEMIA: A COMPARISON WITH PERIPHERAL BLOOD WT1 MRNA EXPRESSIONS
Ishiyama, K.
Miyawaki, S.
Kitamura, K.
Suzuki, K.
Ishikawa, J.
Ogawa, H.
Imai, K.
Naoe, T.
Chiba, S.
Miyazaki, Y.
Hatta, Y.
Kurokawa, M.
Ueda, Y.
Koga, D.
Sugiyama, H.
Takaku, F.
HAEMATOLOGICA, 2014, 99 : 307 - 308
[45] Correlation of WT1 expression with the burden of total and residual leukemic blasts in bone marrow samples of acute myeloid leukemia patients
Manuel Alonso-Dominguez, Juan
Tenorio, Maria
Velasco, Diego
Abalo, Lorena
Lozano, Sara
Villarrubia, Jesus
Lopez-Jimenez, Javier
Grande, Silvia
Ayala, Rosa
CANCER GENETICS, 2012, 205 (04) : 190 - 191
[46] WT1 AS PROGNOSTIC MARKER IN MIELODYSPLASTIC SYNDROMES
Pascale, S. P.
Nuccorini, R.
Coluzzi, S.
Tramutoli, A.
Gioia, G.
Amendola, A.
Cimminiello, M.
Filardi, N.
Matturro, A.
Vertone, D.
Pizzuti, M.
HAEMATOLOGICA, 2019, 104 : 110 - 110
[47] Bone marrow failure syndromes
Marsh, JCW
CLINICAL MEDICINE, 2005, 5 (04) : 332 - 336
[48] Bone marrow failure syndromes
Alter, BP
CLINICS IN LABORATORY MEDICINE, 1999, 19 (01) : 113 - +
[49] Wilms Tumor Gene (WT1) Expression as a Panleukemic Marker
Hans D. Menssen
Jan M. Siehl
Eckhard Thiel
International Journal of Hematology, 2002, 76 : 103 - 109
[50] Wilms tumor gene (WT1) expression as a panleukemic marker
Menssen, HD
Siehl, JM
Thiel, E
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (02) : 103 - 109

← 1 2 3 4 5 →